MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 28.12.2024
Abcam plc P/E 2011-2026 | ABCM
P/E Jährlich Abcam plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.21 K | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in GBP-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.21 K | 1.21 K | 1.21 K |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M |  USA |
 |
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M |  Canada |
 |
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | USA |
 |
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | France |
 |
Ascendis Pharma A/S
ASND
|
-19.2 | $ 220.94 | 2.51 % | $ 5 B |  Danmark |
 |
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | USA |
 |
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | USA |
 |
MediWound Ltd.
MDWD
|
-14.3 | $ 17.08 | 2.83 % | $ 465 M |  Israel |
 |
Amphastar Pharmaceuticals
AMPH
|
12.7 | $ 19.7 | 2.44 % | $ 921 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | USA |
 |
Mesoblast Limited
MESO
|
-14.2 | $ 15.54 | 8.48 % | $ 10.1 B |  Australia |
 |
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | Israel |
 |
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | USA |
 |
Atreca
BCEL
|
-0.504 | - | -11.76 % | $ 5.79 M | USA |
 |
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Mirum Pharmaceuticals
MIRM
|
-233 | $ 90.9 | 3.44 % | $ 4.56 B | USA |
 |
bluebird bio
BLUE
|
-0.316 | - | - | $ 546 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - |  Russia |
 |
Cara Therapeutics
CARA
|
-0.457 | - | -3.03 % | $ 260 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | USA |
 |
MediciNova
MNOV
|
-5.77 | $ 1.44 | -0.68 % | $ 70.7 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.92 | $ 1.36 | 3.03 % | $ 347 M | Britain |
 |
CytomX Therapeutics
CTMX
|
-53.6 | $ 4.41 | 3.98 % | $ 608 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-0.498 | - | -5.98 % | $ 34.1 M | USA |
 |
ChemoCentryx
CCXI
|
-0.0138 | - | - | $ 3.74 B | USA |
 |
Merck & Co.
MRK
|
17 | $ 118.9 | 2.17 % | $ 297 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
63.3 | - | - | $ 2.02 B | USA |
 |
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | USA |
 |
Enochian Biosciences
ENOB
|
-0.649 | - | - | $ 40.5 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | Germany |
 |
Bellerophon Therapeutics
BLPH
|
-3.96 | - | -74.18 % | $ 955 K | USA |
 |
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | USA |
 |
Neurocrine Biosciences
NBIX
|
34.9 | $ 131.82 | 3.1 % | $ 13.1 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
-25.3 | $ 4.56 | 5.68 % | $ 874 M | Canada |
 |
Homology Medicines
FIXX
|
-15.3 | - | 0.77 % | $ 53.4 M | USA |
 |
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | USA |
 |
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | USA |
 |
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | USA |